IWM
PLSE icon

IHT Wealth Management’s Pulse Biosciences PLSE Stock Holding History

IHT Wealth Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,166
Closed -$16K – 1095
2018
Q1 		$16K Hold
1,166
– – ﹤0.01% 1051
2017
Q4 		$28K Buy
1,166
+100
+9% +$2.36K 0.01% 886
2017
Q3 		$20K Hold
1,066
– – 0.01% 780
2017
Q2 		$7 Buy
1,066
+142
+15% +$3.9K ﹤0.01% 1044
2017
Q1 		$16K Buy
+924
New +$12.6K 0.01% 711

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

IHT Wealth Management's PLSE Position: Q2 2018 in Review

IHT Wealth Management sold out of Pulse Biosciences (PLSE) in Q2 2018, closing a stake of 1,166 shares — an estimated $16K sold.

IHT Wealth Management first reported a position in PLSE in Q1 2017 and held it in 5 quarters. The position peaked at $28K in Q4 2017. 43 funds tracked by Wall St. Rank hold PLSE as of Q2 2018.

  • IHT Wealth Management reported no remaining Pulse Biosciences position as of Q2 2018 after selling out during the quarter.
  • IHT Wealth Management sold 1,166 Pulse Biosciences shares in Q2 2018, an estimated $16K.
  • IHT Wealth Management first reported a position in Pulse Biosciences in Q1 2017 and held it in 5 quarters.
  • IHT Wealth Management's Pulse Biosciences position peaked at $28K in Q4 2017.
  • 43 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.